NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers
Portfolio Pulse from Benzinga Newsdesk
NanoString Technologies, Inc. (NASDAQ:NSTG) has announced three new partnerships with Contract Research Organizations (CRO) Macrogen, Propath UK, and Sirona Dx. These partnerships will provide global biopharma customers with new access to CosMx™ SMI technology for translational drug development.
September 07, 2023 | 10:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NanoString's new partnerships with Macrogen, Propath UK, and Sirona Dx could potentially increase the company's market reach and revenue through the expanded use of its CosMx™ SMI technology.
The new partnerships with Macrogen, Propath UK, and Sirona Dx will provide NanoString with an expanded customer base for its CosMx™ SMI technology. This could potentially lead to increased sales and revenue for the company, positively impacting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100